Web Desk. The COVID-19 vaccine, developed by Pfizer and BioNTech, has been shown to significantly reduce the spread of the new coronavirus. The results indicate that the vaccine significantly reduces the spread of the virus, while also significantly reducing the number of symptomatic and asymptomatic cases.
A study released in Israel on 19 February found that the vaccine reduced the number of cases of COVID-19 symptoms by 85% in 15 to 28 days, while the rate of cases without symptoms was 75%.
Medical experts say the latest findings are a significant development. A 75% or 90% reduction does not mean a significant reduction in the spread of the virus. This means that it not only protects the vaccine user but also protects those around them.
The researchers said that the vaccine is a very good weapon against coronavirus and the results of its use are encouraging. The study was conducted jointly by experts from the Israeli Ministry of Health and Pfizer. The study also found that the vaccine was up to 81% effective against a new strain of the virus discovered in the UK.
The data from the results were obtained from an ongoing vaccination campaign in Israel, which indicates that the virus is preventing the spread of the virus in the real world. It should be noted that about 50% of the population in Israel has been given at least one dose of the Pfizer and BioNTech vaccine.